Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 2Carcinoma 2Urinary Incontinence 1Squamous Cell Carcinoma of Head and Neck 1Pyridoxine-dependent epilepsy 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Erectile Dysfunction 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Tadalafil 1Surveys and Questionnaires 1Saline Solution 1Holistic Health 1Educational Status 1Cell- and Tissue-Based Therapy 1Androgen Antagonists 1Ambulatory Care Facilities 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erectile Dysfunction × Tadalafil × 1 year × Clear all
NCT07576335 2026-05-08

ROBOPREP

Surgical Outcomes Research Centre (SOuRCe)

Phase 2 Not yet recruiting
64 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡